FindTrial
Sign In

FGF21 and LIN28A expression in lung cancer tissue and their correlation with clinicopathological characteristics

FGF21 and LIN28A expression in lung cancer tissue and their correlation with clinicopathological characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125826
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Lung cancer tissue group:NA

Sponsors

Guang'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This was the first detection of lung tumours in these patients; all underwent radical lung cancer surgery, accompanied by standard lymph node dissection.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of other malignant tumors; 2.Previously received radiotherapy and chemotherapy; 3.Combined with severe heart, liver, or kidney diseases; 4.Combined with severe infection;

Design outcomes

Primary

MeasureTime frame
LIN28A expression in lung tissue;FGF21 expression in lung tissue;—

Countries

China

Contacts

Public ContactDeng Taibing

Guang'an People's Hospital

565339482@qq.com+86 826 2600309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026